CORY ANDREW MCMAHON
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family FORDYCE, AR NPI 1679176002
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family AR ABBVIE INC. All categories
General Payments — all program years on this page
$258.77
- Category: General Payments
- Program years: PY2021–2024
- Record count: 16
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $119.75 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $119.75 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $58.48 | 4 |
| Xeris Pharmaceuticals, Inc. | $28.10 | 2 |
| Neurocrine BioSciences, Inc. | $16.63 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.54 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1107639170 | ABBVIE INC. | $13.20 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1107639172 | ABBVIE INC. | $13.26 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1107639174 | ABBVIE INC. | $17.02 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1107639176 | ABBVIE INC. | $15.00 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118105801 | Boehringer Ingelheim Pharmaceuticals, Inc. | $16.54 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144623567 | Xeris Pharmaceuticals, Inc. | $14.15 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144623569 | Xeris Pharmaceuticals, Inc. | $13.95 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150996742 | Neurocrine Biosciences, Inc. | $16.63 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.